SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andrei Sibaev, Birol Yuece, Hans Dieter Allescher, Dieter Saur, Martin Storr, Manfred Kurjak, The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats, Pharmacological Reports, 2014, 66, 2, 256

    CrossRef

  2. 2
    Kun Li, Jakub Fichna, Rudolf Schicho, Dieter Saur, Mohammad Bashashati, Ken Mackie, Yongyu Li, Andreas Zimmer, Burkhard Göke, Keith A. Sharkey, Martin Storr, A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice, Neuropharmacology, 2013, 71, 255

    CrossRef

  3. 3
    Nicholas T. Bello, Janelle W. Coughlin, Graham W. Redgrave, Ellen E. Ladenheim, Timothy H. Moran, Angela S. Guarda, Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density, Physiology & Behavior, 2012, 105, 3, 720

    CrossRef

  4. 4
    Mireille Alhouayek, Giulio G. Muccioli, The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity, Trends in Molecular Medicine, 2012, 18, 10, 615

    CrossRef

  5. You have free access to this content5
    V. Di Marzo, F. Piscitelli, Gut feelings about the endocannabinoid system, Neurogastroenterology & Motility, 2011, 23, 5
  6. 6
    Zhen Pang, Nancy N. Wu, Weiguang Zhao, David C. Chain, Erica Schaffer, Xin Zhang, Preeti Yamdagni, Vaseem A. Palejwala, Chunpeng Fan, Sarah G. Favara, Holly M. Dressler, Kyriakos D. Economides, Daniel Weinstock, Jean S. Cavallo, Souad Naimi, Anne-Marie Galzin, Etienne Guillot, Marie-Pierre Pruniaux, Michael J. Tocci, H. Greg Polites, The Central Cannabinoid CB1 Receptor Is Required for Diet-Induced Obesity and Rimonabant's Antiobesity Effects in Mice, Obesity, 2011, 19, 10
  7. You have free access to this content7
    B. Yüce, M. Kemmer, G. Qian, M. Müller, A. Sibaev, Y. Li, M. E. Kreis, M. Storr, Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat, Neurogastroenterology & Motility, 2010, 22, 6
  8. 8
    Angelo A. Izzo, Keith A. Sharkey, Cannabinoids and the gut: New developments and emerging concepts, Pharmacology & Therapeutics, 2010, 126, 1, 21

    CrossRef

  9. You have free access to this content9
    M. A. Storr, M. Bashashati, C. Hirota, V. K. Vemuri, C. M. Keenan, M. Duncan, B. Lutz, K. Mackie, A. Makriyannis, W. K. Macnaughton, K. A. Sharkey, Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice, Neurogastroenterology & Motility, 2010, 22, 7
  10. You have free access to this content10
    Y.-y. Li, Y.-n. Li, J.-b. Ni, C.-j. Chen, S. Lv, S.-y. Chai, R.-h. Wu, B. Yüce, M. Storr, Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus, Neurogastroenterology & Motility, 2010, 22, 3
  11. 11
    Rudolf Schicho, Martin Storr, Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies, Expert Review of Clinical Pharmacology, 2010, 3, 2, 193

    CrossRef

  12. You have free access to this content12
    S Baldassano, MG Zizzo, R Serio, F Mulè, Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum, British Journal of Pharmacology, 2009, 158, 1
  13. 13
    Francesca Borrelli, Angelo A. Izzo, Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance, Best Practice & Research Clinical Endocrinology & Metabolism, 2009, 23, 1, 33

    CrossRef

  14. 14
    Paul Cavuoto, Gary A. Wittert, The role of the endocannabinoid system in the regulation of energy expenditure, Best Practice & Research Clinical Endocrinology & Metabolism, 2009, 23, 1, 79

    CrossRef

  15. 15
    R Capasso, F Borrelli, G Aviello, B Romano, C Scalisi, F Capasso, A A Izzo, Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice, British Journal of Pharmacology, 2008, 154, 5
  16. You have free access to this content16
    D. De Filippis, T. Iuvone, A. D'amico, G. Esposito, L. Steardo, A. G. Herman, P. A. Pelckmans, B. Y. De Winter, J. G. De Man, Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase, Neurogastroenterology & Motility, 2008, 20, 8
  17. 17
    Jean Fioramonti, Lionel Bueno, Role of cannabinoid receptors in the control of gastrointestinal motility and perception, Expert Review of Gastroenterology & Hepatology, 2008, 2, 3, 385

    CrossRef

  18. 18
    M. A. Storr, B. Yüce, C. N. Andrews, K. A. Sharkey, The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome, Neurogastroenterology & Motility, 2008, 20, 8